The Phase I/II clinical trials of the world’s first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biological Products under the China National Biotec Group affiliated to the China National Pharmaceutical Group, produced antibodies in every participant, it was announced on Tuesday.
June 23, 2020
· 3 min read
